Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Galmed Pharmaceuticals ( (GLMD) ) just unveiled an announcement.
Galmed Pharmaceuticals has called a Special General Meeting of shareholders for March 4, 2026, in Ramat Gan, Israel, to vote on a framework authorizing a reverse split of its ordinary shares at a ratio between 1-for-2 and 1-for-250, with implementation details left to the board for up to 18 months. The move follows a January 29, 2026 notice from Nasdaq that Galmed’s shares, which closed at $0.6639 on February 6, 2026, no longer meet the $1.00 minimum bid price requirement, and the proposed reverse split is primarily intended to lift the share price to regain compliance and preserve the company’s Nasdaq listing, a key issue for shareholders and market positioning.
The most recent analyst rating on (GLMD) stock is a Hold with a $0.68 price target. To see the full list of analyst forecasts on Galmed Pharmaceuticals stock, see the GLMD Stock Forecast page.
Spark’s Take on GLMD Stock
According to Spark, TipRanks’ AI Analyst, GLMD is a Neutral.
The score is weighed down mainly by weak financial performance (no revenue, ongoing losses, and continued cash burn), with technicals also bearish as the stock trades below all major moving averages and momentum indicators remain negative. A debt-free balance sheet provides some stabilization but is not enough to offset the core operating risks.
To see Spark’s full report on GLMD stock, click here.
More about Galmed Pharmaceuticals
Galmed Pharmaceuticals Ltd. is a biopharmaceutical company based in Ramat Gan, Israel, whose ordinary shares are listed on the Nasdaq Capital Market. The company operates in the pharmaceutical industry and is subject to Nasdaq’s listing standards, including minimum bid price requirements for continued trading on the exchange.
Average Trading Volume: 2,130,460
Technical Sentiment Signal: Strong Sell
Current Market Cap: $3.64M
For a thorough assessment of GLMD stock, go to TipRanks’ Stock Analysis page.